Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007475 |
---|---|
Receipt number | R000008808 |
Scientific Title | A randomized phase II study of Erlotinib with or without Bevacizumab in NSCLC patients previouly treated with platinum-based chemotherapy containing bevacizumab. North Japan Lung Cancer Study Group Trial 1201 |
Date of disclosure of the study information | 2012/03/09 |
Last modified on | 2014/09/09 11:51:33 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/03/09 16:37:52 | ||
2 | Update | 2012/03/29 08:58:34 | Recruitment status |
|
3 | Update | 2013/01/07 16:50:11 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
4 | Update | 2013/03/01 12:48:41 | Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
5 | Update | 2013/03/11 12:51:10 | Email1 |
|
6 | Update | 2013/09/09 12:42:53 | Address TEL Address Address TEL Address |
|
7 | Update | 2014/09/09 11:51:33 | Recruitment status |